Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03319212 · ClinicalTrials.gov registry record · NA
Clinical Characterization of Symptomatic Populations
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT03319212 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 105 participants.
The verdict
NCT03319212, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This is an unmasked, non-randomized, single arm, stratified, dispensing investigation of symptomatic and asymptomatic subject populations. Subjects will be assigned to a single study lens type to be worn bilaterally for approximately 4 weeks followed by no contact lens wear for 1 week.
Interventions
- DEVICE senofilcon A contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2017-09-29 |
| Est. Completion | 2018-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03319212
The ClinicalTrials.gov registry entry for NCT03319212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which senofilcon A contact lenses is the first listed.
NCT03319212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03319212 about?
NCT03319212 is a clinical study titled "Clinical Characterization of Symptomatic Populations". This is an unmasked, non-randomized, single arm, stratified, dispensing investigation of symptomatic and asymptomatic subject populations. Subjects will be assigned to a single study lens type to be worn bilaterally for approximately 4 weeks followed by no contact lens wear for 1 week.
What is the current status of trial NCT03319212?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2017-09-29. Estimated completion is 2018-08-15.
What interventions are being tested in trial NCT03319212?
The interventions under investigation include: senofilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT03319212?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.